Company Quick10K Filing
Premier Biomedical
10-K 2019-12-31 Filed 2020-05-15
S-1 2019-12-10 Public Filing
10-Q 2019-09-30 Filed 2019-11-14
10-Q 2019-06-30 Filed 2019-08-14
10-Q 2019-03-31 Filed 2019-05-15
10-K 2018-12-31 Filed 2019-04-15
10-Q 2018-09-30 Filed 2018-11-26
10-Q 2018-06-30 Filed 2018-08-20
S-1 2018-04-26 Public Filing
10-Q 2018-03-31 Filed 2018-05-23
10-K 2017-12-31 Filed 2018-04-12
10-Q 2017-09-30 Filed 2017-11-21
10-Q 2017-06-30 Filed 2017-08-21
10-Q 2017-03-31 Filed 2017-05-22
10-K 2016-12-31 Filed 2017-05-09
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-17
10-Q 2016-03-31 Filed 2016-05-16
10-K 2015-12-31 Filed 2016-03-30
10-Q 2015-09-30 Filed 2015-11-24
10-Q 2015-06-30 Filed 2015-08-14
10-Q 2015-03-31 Filed 2015-05-15
10-K 2014-12-31 Filed 2015-03-31
10-Q 2014-09-30 Filed 2014-11-18
10-Q 2014-06-30 Filed 2014-08-14
10-K 2013-12-31 Filed 2014-03-31
10-Q 2013-09-30 Filed 2013-11-12
10-Q 2013-06-30 Filed 2013-08-12
10-Q 2013-03-31 Filed 2013-05-15
10-K 2012-12-31 Filed 2013-04-01
10-Q 2012-09-30 Filed 2012-11-19
10-Q 2012-06-30 Filed 2012-08-14
10-Q 2012-03-31 Filed 2012-05-16
10-K 2011-12-31 Filed 2012-03-23
8-K 2020-05-26
8-K 2020-05-22
8-K 2020-05-15
8-K 2020-05-11
8-K 2020-05-02
8-K 2020-03-30
8-K 2019-10-04
8-K 2019-09-13
8-K 2019-08-16
8-K 2019-08-07
8-K 2019-07-30
8-K 2019-07-08
8-K 2019-06-12
8-K 2019-04-26
8-K 2019-04-17
8-K 2019-03-29
8-K 2018-11-23
8-K 2018-05-29
8-K 2018-03-01

Premier Biomedical Financials

BIEI Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Triton Emission Solutions (DSOX) 0 0.0 -10,306% 20 18,837 0 0 -2,068 -831 -1
Ozop Surgical (OZSC) 0 90% -0.7 -71% 6,256 10,414 85 76 -4,437 -2,958 1,985
X Rail Entertainment (XREE) 0 -0.1 -1,441,401% 0 3,429 0 0 -5,261 -5,732 345
OncBioMune (OBMP) 0 0.0 -1,707% 413 14,090 0 0 -7,048 -5,617 -136
PropTech Acquisition Corp (PTACU)
Data Call Technologies (DCLT) 0 70% 0.7 -21% 101 73 463 323 -21 -19 -13
DigitalTown (DGTW) 0 12,618% 0.0 -16,557% 34 2,761 -2 -220 -5,706 -5,268 -34
GIFA (FRFS) 0 63% -0.9 43% 80 362 98 62 34 34 -30
Bulova Technologies (BTGI)
Highcom Global Security (HCGS) 0 41% -0.8 1% 9,334 1,222 4,918 2,033 57 172 -131
True Drinks Holdings (TRUU) 0 57% 1.7 -26% 9,780 7,642 12,437 7,052 -2,515 -2,482 -4,166
Bingo Nation (BLTO)
Jiayin Group (JFIN)
Cantabio Pharmaceuticals (CTBO) 0 0.9 -474% 326 2,215 0 0 -1,543 -331 -283
Electromedical Technologies (ELCQ)
Premier Biomedical (BIEI) 0 58% -0.3 -183% 186 2,304 13 8 -340 -238 75
Amplitude Healthcare (AMHCU)
Natcore Technology (NXT)
PetLife Pharmaceuticals (PTLF) 0 -0.1 -47,202% 8 1,981 0 0 -3,708 -3,708 205
Intercloud Systems (ICLD) 0 21% -1.3 -92% 9,928 40,762 10,074 2,119 -9,147 -8,136 10,297

Balance Sheet ($'000)2012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash3734017345741611419947103962673353939282221012510384791063878187117
Accounts Receivable100023223
Inventory
PP&E23334433355444766557657665798
Assets17105431774878251232356412111243917061564639224273225209199176228165155155186
Accounts Payable143089162949912218433514720923829918883144210221178163350347347348307264268225193
Long-Term Debt7015118133129651782111841530069170155218304310253250192
Liabilities14601191981481802752160531883594205163473608018647005,3586,5052,8852,8202,1262,2032,4722,3122,1282,2982,304
Stockholders' Equity344-76-21-99-102-24910217511-68-247-377-426-276-299-744-817-661-5,134-6,232-2,660-2,611-1,927-2,027-2,244-2,147-1,973-2,143-2,118
Income Statement ($'000)2012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue000000000000000000000241510128643
Cost of Revenue11146104222
Gross Profit131424422
R&D8438583735226116117576011050468001840053
SG&A101772,3192,311671508373197303533675980635278100-254108445492485750
Tax00000000000000000000000000000
Net Income-27-59-1,601-2,633-213-1,033-998-307516-247-646-1,267-937-189-189-415-722-435-196-5,329-1,2473,722-909566-100-36469-227-182
Cash Flow ($'000)2012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-23-54-73-134-90-131-304-114-153-68-122-69-78-193-239-85-79-81-114-232-25-139-62-129-127-68-107-98
Cash Investing0-100-10000-2-4000-2-320-200-3-20
Cash Financing022206612074402200012611501251552458569753031500120606018065115128